{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:43:32Z","timestamp":1760147012017,"version":"build-2065373602"},"reference-count":21,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Pregnant women who receive the COVID-19 vaccine develop anti-SARS-CoV-2 antibodies, which can be transferred to the fetus. However, the effectiveness of placental transfer has not been evaluated in twin pregnancy, especially in cases vaccinated with heterologous CoronaVac (Sinovac)\u2014ChAdOx1 (Oxford-AstraZeneca) regimen, which was commonly used in many countries. Case: A 34-year-old Thai woman with a twin pregnancy attended our antenatal care clinic at 21 + 2 weeks of gestation and requested COVID-19 vaccination. Her medical history and physical examination were unremarkable. She had not received COVID-19 vaccination before. Ultrasound screening for fetal anomaly revealed a dichorion diamnion twin pregnancy. Both twins showed no structural anomaly. She received the CoronaVac vaccine at 21 + 2 weeks of gestation without serious side effects and the ChAdOx1 vaccine at 24 + 2 weeks of gestation. Cesarean delivery was performed at 36 + 5 weeks of gestation, giving birth to the two healthy babies. The levels of anti-spike protein IgG levels (BAU\/mL) in maternal blood just before delivery and umbilical cord blood of the two newborns were 313.349, 678.219, and 874.853, respectively. The levels of % inhibition (wild-type and delta) in the two newborns were also higher than those in the mother. In conclusion, heterologous CoronaVac-ChAdOx1-S vaccination in a twin pregnancy could effectively provide protective immunity to both twin newborns. The antibody levels in both were approximately two times higher than those in the mothers. This case report may serve as a reference in counseling couples with a twin pregnancy, while the studies on placental transfer of vaccine-derived antibodies in twin pregnancy are currently not available, especially in countries experiencing a vaccine shortage or unavailability of mRNA vaccines.<\/jats:p>","DOI":"10.3390\/vaccines11010116","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T01:42:44Z","timestamp":1672796564000},"page":"116","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Placental Transfer Immunity to the Newborns in a Twin Pregnant Women Vaccinated with Heterologous CoronaVac-ChAdOx1"],"prefix":"10.3390","volume":"11","author":[{"given":"Saipin","family":"Pongsatha","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kriangkrai","family":"Chawansuntati","sequence":"additional","affiliation":[{"name":"Research Institute for Health Sciences, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0419-2201","authenticated-orcid":false,"given":"Supachai","family":"Sakkhachornphop","sequence":"additional","affiliation":[{"name":"Research Institute for Health Sciences, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3389-6478","authenticated-orcid":false,"given":"Theera","family":"Tongsong","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,3]]},"reference":[{"key":"ref_1","unstructured":"Centers for Disease Control and Prevention (2022). Pregnant People at Increased Risk for Severe Illness from COVID-19, Centers for Disease Control and Prevention."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"m3320","DOI":"10.1136\/bmj.m3320","article-title":"Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: Living systematic review and meta-analysis","volume":"370","author":"Allotey","year":"2020","journal-title":"BMJ"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"510.e1","DOI":"10.1016\/j.ajog.2020.11.022","article-title":"Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls","volume":"224","author":"DeBolt","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Khan, D.S.A., Pirzada, A.N., Ali, A., Salam, R.A., Das, J.K., and Lassi, Z.S. (2021). The Differences in Clinical Presentation, Management, and Prognosis of Laboratory-Confirmed COVID-19 between Pregnant and Non-Pregnant Women: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18115613"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jamapediatrics.2021.1050","article-title":"Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study","volume":"175","author":"Villar","year":"2021","journal-title":"JAMA Pediatr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jamainternmed.2022.2442","article-title":"Association of COVID-19 Vaccination During Pregnancy With Incidence of SARS-CoV-2 Infection in Infants","volume":"182","author":"Carlsen","year":"2022","journal-title":"JAMA Intern. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/jamapediatrics.2021.0038","article-title":"Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios","volume":"175","author":"Flannery","year":"2021","journal-title":"JAMA Pediatr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e2030455","DOI":"10.1001\/jamanetworkopen.2020.30455","article-title":"Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic","volume":"3","author":"Edlow","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000525625","article-title":"Does Maternal SARS-CoV-2 Infection or SARS-CoV-2 Vaccination Trigger an Inflammatory Response in the Fetus? A Prospective Cohort Study","volume":"87","author":"Alhousseini","year":"2022","journal-title":"Gynecol. Obstet. Investig."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI154834","article-title":"Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine","volume":"131","author":"Beharier","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajog.2021.03.035","article-title":"Cord blood antibodies following maternal coronavirus disease 2019 vaccination during pregnancy","volume":"225","author":"Mithal","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Popescu, D.E., C\u00eetu, C., Jura, A.M.C., Lungu, N., Navolan, D., Craina, M., Semenescu, A., Gorun, F., Jura, M.A., and Belengeanu, V. (2022). The Benefits of Vaccination against SARS-CoV-2 during Pregnancy in Favor of the Mother\/Newborn Dyad. Vaccines, 10.","DOI":"10.3390\/vaccines10060848"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1038\/s41467-022-32188-1","article-title":"Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and infancy","volume":"13","author":"Prahl","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2029111","DOI":"10.1080\/21645515.2022.2029111","article-title":"Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: A prospective cohort study","volume":"18","author":"Wanlapakorn","year":"2022","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Mahasirimongkol, S., Khunphon, A., Kwangsukstid, O., Sapsutthipas, S., Wichaidit, M., Rojanawiwat, A., Wichuckchinda, N., Puangtubtim, W., Pimpapai, W., and Soonthorncharttrawat, S. (2022). The Pilot Study of Immunogenicity and Adverse Events of a COVID-19 Vaccine Regimen: Priming with Inactivated Whole SARS-CoV-2 Vaccine (CoronaVac) and Boosting with the Adenoviral Vector (ChAdOx1 nCoV-19) Vaccine. Vaccines, 10.","DOI":"10.3390\/vaccines10040536"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Munoz, F.M., Posavad, C.M., Richardson, B.A., Badell, M.L., Bunge, K., Mulligan, M.J., Parameswaran, L., Kelly, C., Olsen-Chen, C., and Novak, R.M. (2022). COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn (DMID 21-0004). medRxiv.","DOI":"10.1101\/2022.06.13.22276354"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e0385","DOI":"10.1590\/0037-8682-0385-2021","article-title":"Vertical transmission of maternal COVID-19 antibodies after CoronaVac vaccine: A case report","volume":"54","author":"Menegali","year":"2021","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"103103","DOI":"10.1016\/j.amsu.2021.103103","article-title":"Covid-19 vaccine and its consequences in pregnancy: Brief review","volume":"72","author":"Leik","year":"2021","journal-title":"Ann. Med. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e603","DOI":"10.1093\/cid\/ciac135","article-title":"The Effect of Gestational Age at BNT162b2 mRNA Vaccination on Maternal and Neonatal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Levels","volume":"75","author":"Rottenstreich","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/AOG.0000000000004693","article-title":"Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery","volume":"139","author":"Yang","year":"2022","journal-title":"Obstet. Gynecol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/intimm\/13.8.993","article-title":"The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans","volume":"13","author":"Firan","year":"2001","journal-title":"Int. Immunol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/1\/116\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T17:57:31Z","timestamp":1760119051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/1\/116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,3]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["vaccines11010116"],"URL":"https:\/\/doi.org\/10.3390\/vaccines11010116","relation":{},"ISSN":["2076-393X"],"issn-type":[{"type":"electronic","value":"2076-393X"}],"subject":[],"published":{"date-parts":[[2023,1,3]]}}}